ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,383Medicare Part D Prescriptions Filled, Including Refills

Rank: 253 out of 4623

$703K Total Retail Price of All Prescriptions

Rank: 364 out of 4623

530 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 530 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 11,256 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
AMLODIPINE BESYLATE 836 739 1 5
PRAVASTATIN SODIUM 798 693 2 11
LISINOPRIL 580 514 3 4
GLIMEPIRIDE 399 310 4 38
METFORMIN HCL ER 336 266 5 51
DONEPEZIL HCL 329 324 6 30
LEVOTHYROXINE SODIUM 326 270 7 1
JANUVIA 325 250 8 52
TAMSULOSIN HCL 308 292 9 29
FAMOTIDINE 267 231 10 82
LOSARTAN-HYDROCHLOROTHIAZIDE 260 238 11 46
NEXIUM 260 227 11 17
LOSARTAN POTASSIUM 237 213 13 21
METOPROLOL SUCCINATE 232 209 14 13
HYDROCODONE-ACETAMINOPHEN 231 178 S3 15 3
GABAPENTIN 227 213 16 16
ATORVASTATIN CALCIUM 218 168 17 12
GLYBURIDE-METFORMIN HCL 195 151 R 18 56
TRAMADOL HCL 190 133 19 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 185 159 20 19
CLOPIDOGREL 172 144 21 31
CRESTOR 170 134 22 20
DIOVAN HCT 157 144 23 67
OMEPRAZOLE 153 124 24 7
LANTUS 153 112 24 44
FUROSEMIDE 144 134 26 8
METOPROLOL TARTRATE 136 121 27 9
DIOVAN 133 125 28 39
IBUPROFEN 130 112 29 65
MELOXICAM 121 111 30 27
CITALOPRAM HBR 115 99 31 23
CHLORTHALIDONE 113 111 32 194
TRAMADOL HCL-ACETAMINOPHEN 103 97 33 103
PLAVIX 101 87 34 45
AZITHROMYCIN 99 81 35 33
NAMENDA 97 97 36 36
NAPROXEN 94 63 37 63
CIPROFLOXACIN HCL 90 77 38 43
RANITIDINE HCL 89 82 39 47
SIMVASTATIN 88 86 40 2
DICLOFENAC SODIUM 83 56 41 121
ENALAPRIL MALEATE 79 44 42 41
EXFORGE 78 73 43 181
CLONIDINE HCL 77 58 44 40
HYDROCHLOROTHIAZIDE 76 60 45 10
ISOSORBIDE MONONITRATE ER 70 66 46 60
HYDRALAZINE HCL 69 57 47 99
MECLIZINE HCL 69 59 47 125
GLIPIZIDE ER 68 59 49 86
METFORMIN HCL 68 52 49 6
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 55 49 68
GLIPIZIDE XL 68 51 49 184
ZOLPIDEM TARTRATE 66 31 53 18
CLOTRIMAZOLE-BETAMETHASONE 64 55 54 147
INSULIN SYRINGE 61 51 55 85
AMLODIPINE BESYLATE-BENAZEPRIL 58 52 56 55
PANTOPRAZOLE SODIUM 57 39 57 35
LACTULOSE 55 55 58 106
NIFEDIPINE ER 55 41 58 97
LIPITOR 54 44 60 100
ALENDRONATE SODIUM 52 43 61 22
LANTUS SOLOSTAR 52 16 61 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.